SETD2 and nonpapillary renal cell carcinoma: Lastly, comparisons with previous studies, focused on SETD2 mutational status/H3K36me3 prevalence of ccRCC tumors and the resulting effects on splicing [14, 15], suggest that genes subject to splicing defects can also harbor DETs.